These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 35763354)

  • 21. Dynamin 2 the rescue for centronuclear myopathy.
    Demonbreun AR; McNally EM
    J Clin Invest; 2014 Mar; 124(3):976-8. PubMed ID: 24569368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel mutation in the DNM2 gene impairs dynamin 2 localization in skeletal muscle of a patient with late onset centronuclear myopathy.
    Kierdaszuk B; Berdynski M; Karolczak J; Redowicz MJ; Zekanowski C; Kaminska AM
    Neuromuscul Disord; 2013 Mar; 23(3):219-28. PubMed ID: 23374900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amphiphysin (BIN1) negatively regulates dynamin 2 for normal muscle maturation.
    Cowling BS; Prokic I; Tasfaout H; Rabai A; Humbert F; Rinaldi B; Nicot AS; Kretz C; Friant S; Roux A; Laporte J
    J Clin Invest; 2017 Dec; 127(12):4477-4487. PubMed ID: 29130937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insights from genotype-phenotype correlations by novel SPEG mutations causing centronuclear myopathy.
    Wang H; Castiglioni C; Kaçar Bayram A; Fattori F; Pekuz S; Araneda D; Per H; Erazo R; Gümüş H; Zorludemir S; Becker K; Ortega X; Bevilacqua JA; Bertini E; Cirak S
    Neuromuscul Disord; 2017 Sep; 27(9):836-842. PubMed ID: 28624463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Satellite cells deficiency and defective regeneration in dynamin 2-related centronuclear myopathy.
    F Almeida C; Bitoun M; Vainzof M
    FASEB J; 2021 Apr; 35(4):e21346. PubMed ID: 33715228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNM2 mutations in Chinese Han patients with centronuclear myopathy.
    Lin P; Liu X; Zhao D; Dai T; Wu H; Gong Y; Yan C
    Neurol Sci; 2016 Jun; 37(6):995-8. PubMed ID: 26908122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel SPEG Mutations in Congenital Myopathy without Centralized Nuclei.
    Lornage X; Sabouraud P; Lannes B; Gaillard D; Schneider R; Deleuze JF; Boland A; Thompson J; Böhm J; Biancalana V; Laporte J
    J Neuromuscul Dis; 2018; 5(2):257-260. PubMed ID: 29614691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mild congenital myopathy due to a novel variation in
    Yildirim M; Balasar O; Kose E; Dogan MT
    Intractable Rare Dis Res; 2021 Aug; 10(3):220-222. PubMed ID: 34466346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BIN1 modulation in vivo rescues dynamin-related myopathy.
    Lionello VM; Kretz C; Edelweiss E; Crucifix C; Gómez-Oca R; Messaddeq N; Buono S; Koebel P; Massana Muñoz X; Diedhiou N; Cowling BS; Bitoun M; Laporte J
    Proc Natl Acad Sci U S A; 2022 Mar; 119(9):. PubMed ID: 35217605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tamoxifen improves muscle structure and function of Bin1- and Dnm2-related centronuclear myopathies.
    Gineste C; Simon A; Braun M; Reiss D; Laporte J
    Brain; 2023 Jul; 146(7):3029-3048. PubMed ID: 36562127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutant BIN1-Dynamin 2 complexes dysregulate membrane remodeling in the pathogenesis of centronuclear myopathy.
    Fujise K; Okubo M; Abe T; Yamada H; Nishino I; Noguchi S; Takei K; Takeda T
    J Biol Chem; 2021; 296():100077. PubMed ID: 33187981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Centronuclear Myopathy Caused by Defective Membrane Remodelling of Dynamin 2 and BIN1 Variants.
    Fujise K; Noguchi S; Takeda T
    Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subtle central and peripheral nervous system abnormalities in a family with centronuclear myopathy and a novel dynamin 2 gene mutation.
    Echaniz-Laguna A; Nicot AS; Carré S; Franques J; Tranchant C; Dondaine N; Biancalana V; Mandel JL; Laporte J
    Neuromuscul Disord; 2007 Dec; 17(11-12):955-9. PubMed ID: 17825552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathological features of centronuclear myopathy in Japanese populations harboring mutations in dynamin 2.
    Mori-Yoshimura M; Okuma A; Oya Y; Fujimura-Kiyono C; Nakajima H; Matsuura K; Takemura A; Malicdan MC; Hayashi YK; Nonaka I; Murata M; Nishino I
    Clin Neurol Neurosurg; 2012 Jul; 114(6):678-83. PubMed ID: 22613877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrated multi-omics approach reveals the role of striated muscle preferentially expressed protein kinase in skeletal muscle including its relationship with myospryn complex.
    Li Q; Lin J; Luo S; Schmitz-Abe K; Agrawal R; Meng M; Moghadaszadeh B; Beggs AH; Liu X; Perrella MA; Agrawal PB
    J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):1003-1015. PubMed ID: 38725372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defects in amphiphysin 2 (BIN1) and triads in several forms of centronuclear myopathies.
    Toussaint A; Cowling BS; Hnia K; Mohr M; Oldfors A; Schwab Y; Yis U; Maisonobe T; Stojkovic T; Wallgren-Pettersson C; Laugel V; Echaniz-Laguna A; Mandel JL; Nishino I; Laporte J
    Acta Neuropathol; 2011 Feb; 121(2):253-66. PubMed ID: 20927630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adult centronuclear myopathies: A hospital-based study.
    Echaniz-Laguna A; Biancalana V; Böhm J; Tranchant C; Mandel JL; Laporte J
    Rev Neurol (Paris); 2013; 169(8-9):625-31. PubMed ID: 23938035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the muscle involvement in dynamin 2-related centronuclear myopathy.
    Fischer D; Herasse M; Bitoun M; Barragán-Campos HM; Chiras J; Laforêt P; Fardeau M; Eymard B; Guicheney P; Romero NB
    Brain; 2006 Jun; 129(Pt 6):1463-9. PubMed ID: 16585051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization and genetic diagnosis of centronuclear myopathies in seven Chinese patients.
    Zhao Y; Zhao Z; Shen H; Bing Q; Hu J
    Neurol Sci; 2018 Dec; 39(12):2043-2051. PubMed ID: 30232666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histopathologic changes in the extraocular muscle in centronuclear myopathy with a Dynamin 2 mutation.
    Hanna N; Bouhenni R; Gupta B; Abu-Amero KK; Wollmann R; Edward DP
    Ophthalmic Genet; 2013; 34(1-2):83-6. PubMed ID: 22924779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.